Hepatocellular Carcinoma | Oncology Today with Dr Neil Love: Management of Hepatocellular Carcinoma
Featuring an interview with Professor Arndt Vogel, including the following topics: Case: A man in his early 40s with hepatitis B virus infection and hepatocellular carcinoma (HCC) with Child-Pugh C, ALBI 3 cirrhosis (0:00) Case: A man in his late 60s with metastatic HCC with Child-Pugh A, ALBI 2 cirrhosis (7:54) Case: A man in his early 70s with rheumatoid arthritis diagnosed with Barcelona Clinic Liver Cancer Stage 2 HCC (10:54) The etiology of HCC and response to immunotherapy (13:20) Evaluating recent first-line Phase III combination trials for unresectable HCC (19:57) Managing treatment-emergent adverse events with combination therapies for advanced HCC (25:47) Potential long-term benefits of immunotherapy-based treatments (29:33) Impact of recent changes in HCC treatment algorithms on the use of local therapy (31:46) Use of neoadjuvant therapy to convert unresectable HCC to resectable disease (37:00) Using tyrosine kinase inhibitors for patients with HCC and comorbidities (44:22) CME information and select publications